R&D investment under incomplete markets

被引：0
|
作者：
Hu, Fan [1 ]
Wu, Yaoyao [2 ]
机构：
[1] Guangdong Univ Finance & Econ, Sch Finance, Guangzhou, Peoples R China
[2] Hubei Univ Econ, Inst Adv Studies Finance & Econ IASFE, Wuhan, Peoples R China
来源：
MANAGERIAL AND DECISION ECONOMICS | 2023年 / 44卷 / 02期
基金：
中国国家自然科学基金;
关键词：
CONSUMPTION;
D O I：
10.1002/mde.3717
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
Entrepreneurs often face undiversifiable idiosyncratic risks from their R&D investments. We extend the real options model of R&D to an incomplete markets environment. We find the effect of market incompleteness on R&D investment is ambiguous. With low technological uncertainty, the agent under incomplete markets over-investment in R&D. However, market incompleteness leads to underinvestment in R&D when the technological uncertainty is high.
引用
收藏
页码：858 / 861
页数：4
相关论文
共 50 条
  • [41] Evolving R&D for emerging markets
    Nature Reviews Drug Discovery, 2010, 9 : 417 - 420
  • [42] R&D in the Global Pharmaceutical Markets
    Kermani, Faiz
    Wollowitz, Susan
    FUTURE OF THE CHEMICAL INDUSTRY, 2009, 1026 : 19 - 45
  • [43] Evolving R&D for emerging markets
    Hughes, Bethan
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (06) : 417 - 420
  • [44] Herron boosts R&D investment
    不详
    AUSTRALASIAN BIOTECHNOLOGY, 2001, 11 (06) : 15 - 15
  • [45] Relocation and investment in R&D by firms
    Juan Carlos Bárcena-Ruiz
    María Begoña Garzón
    Portuguese Economic Journal, 2014, 13 : 25 - 38
  • [46] Decision frameworks and the investment in R&D
    Baker, Erin
    Olaleye, Olaitan
    Reis, Lara Aleluia
    ENERGY POLICY, 2015, 80 : 275 - 285
  • [47] Knowledge sharing and R&D investment
    Sarkar, Abhirup
    ECONOPHYSICS OF MARKETS AND BUSINESS NETWORKS, 2007, : 227 - 232
  • [48] Investigating investment in biopharmaceutical R&D
    Carter, Percy H.
    Berndt, Ernst R.
    DiMasi, Joseph A.
    Trusheim, Mark
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (10) : 673 - 674
  • [49] R&D, investment, and industry dynamics
    Lach, S
    Rob, R
    JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY, 1996, 5 (02) : 217 - 249
  • [50] Investigating investment in biopharmaceutical R&D
    Percy H. Carter
    Ernst R. Berndt
    Joseph A. DiMasi
    Mark Trusheim
    Nature Reviews Drug Discovery, 2016, 15 : 673 - 674
12345